| Léopold Griffuel Prize | |
|---|---|
| Native name | Prix Fondation ARC Léopold Griffuel pour la Recherche sur le Cancer |
| Awarded for | A major breakthrough in the fight against cancer |
| Country | |
| Presented by | Fondation ARC pour la Recherche sur le Cancer |
| Reward | €400,000 total (€200,000 per category) |
| Established | 1970 |
| Website | www |
The Leopold Griffuel Prize (Prix Leopold Griffuel) for translational and clinical research is sponsored by the French ARC Foundation for Cancer Research. It is one of the most significant and prestigious international awards dedicated to cancer research in Europe. [1]
The prize is designed to reward the accomplishments of and encourage further research among the world's leading cancer researchers. Past American recipients of the Griffuel Prize include Samuel Broder, former director of the National Cancer Institute; C. Everett Koop, former U.S. Surgeon General, and Anita Roberts, pioneer in research on TGF-beta.
The award comprises two prizes, each valued at €150,000. The recipient(s) receive €50,000 directly, while the remaining €100,000 is allocated to their host institution to support related scientific work, which must be completed within five years of the award. [2]
Source (to 2005) : ARC